Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ: PHAT · Real-Time Price · USD
10.67
-0.07 (-0.65%)
At close: Mar 6, 2026, 4:00 PM EST
10.46
-0.21 (-1.97%)
After-hours: Mar 6, 2026, 7:39 PM EST
Phathom Pharmaceuticals Market Cap
Phathom Pharmaceuticals has a market cap or net worth of $840.78 million as of March 6, 2026. Its market cap has increased by 121.95% in one year.
Market Cap
840.78M
Enterprise Value
1.30B
1-Year Change
121.95%
Ranking
Category
Stock Price
$10.67
Market Cap Chart
Since October 25, 2019, Phathom Pharmaceuticals's market cap has increased from $527.13M to $840.78M, an increase of 59.50%. That is a compound annual growth rate of 7.61%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SELLAS Life Sciences Group | 899.09M |
| SpyGlass Pharma | 880.25M |
| Arvinas | 877.54M |
| MannKind | 871.92M |
| Janux Therapeutics | 849.82M |
| KalVista Pharmaceuticals | 819.36M |
| Xencor | 818.46M |
| Omeros | 814.65M |